ABOUT US

we aims to bring microRNA medicine (nucleic acid medicine) to the market and patient.

e-NA Biotec Inc. is a drug discovery bio-venture company originating from Gifu University. Based on the research results of professors both, Dr. KITADE and Dr. AKAO at Gifu University for many years, we aim to bring microRNA medicine (nucleic acid medicine) to the market and patients.

Our company was established on January 11, 2018 under program for creating start-ups from advanced research and technology (START) supported by the National Institute of Science and Technology Agency (JST) in Japan.

In the field of nucleic acid medicine, where exponential design exists, we are continuing research and development of the world's first Ras-targeted microRNA medicine using highly chemically modified microRNAs discovered by utilizing our know-how.

MISSION

Through our business, we believe that we can improve the quality of life of patients and contribute to society by creating a new future based on science, based on the knowledge we have gained through our long-standing research on nucleic acids.

MicroRNAs are biomolecules that regulate our individual gene expression in the cell. More than 2600 microRNAs have already been reported in the humans (from miRBase, as of April 2024).

It is believed that an imbalance in the amount of microRNAs in a cell causes cancer and other diseases.
We are focused on microRNAs as potential therapeutics, particularly for unmet or refractory cancers with few treatment options.

Our mission is to advance microRNA drug candidates (seeds) into preclinical and clinical trials as quickly as possible and to make therapeutics available to patients worldwide with unmet medical needs.
Through our business, we believe that we can improve the quality of life for patients and contribute to society by creating a new future based on science, based on the knowledge we have gained from our many years of research on nucleic acids.

COMPANY PROFILE

Name of the Company	e-NA Biotec Inc.
Foundation	11th of Jan, 2018 supported by JST's START project
Location	#302 3-12-3, Inaba St. Gifu city, 500-8043 JAPAN
Representative	Yukio KITADE, PhD, CEO -Professor, Faculty of Engineering, Gifu University, 2001-2016 -Emeritus Professor, Gifu University, 2016 -Specially Appointed Professor, Gifu University since 2016 -Professor, Faculty of Engineering, Aichi Institute of Technology also since 2016 -CEO, e-NA Biotec Inc. since 2018
Special Chief Advisor/ Principal Scientist	Yukihiro AKAO, MD, PhD Emeritus Professor, Gifu University Specialty: Molecular genetics, Oncology and Cancer prevention He still conducts microRNA and phytochemical research.
Scientific Advisor	Tsuyoshi YOKOI, PhD Specialty: Toxicogenomics Emeritus Professor, Nagoya University / Emeritus Professor, Kanazawa University He currently serves as an advisor to some pharmaceutical companies and as an extramural committee member for clinical research at universities.
Technical Advisor	Hideo MARUHASHI, PhD Specialty: Commercial production of active pharmaceutical ingredients (APIs), investigational new drugs (INDs), and intermediates (small-scale to scale-up manufacturing) Advisor, Sanwa Chemiphar Corporation / Advisor, Ace Japan Inc. He was formerly at Wako Pure Chemical Industries, Taiho Pharmaceutical Industries, Mitsubishi Corporation, etc.
Scientific Advisor	Mahmoud Kandeel, DVM, PhD Doctor of Veterinary Medicine（DVM） Specialty: Molecular biology Kafrelsheikh University, Egypt King Faisal University, Saudi Arabia